2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 138.851 | 146.679 | 116.621 | 58.347 | 85.681 | 124.745 | 143.679 | 442.102 | 338.492 | 331.576 |
Total Income - EUR | 145.226 | 151.019 | 126.576 | 79.380 | 85.953 | 125.429 | 148.285 | 442.947 | 357.086 | 332.860 |
Total Expenses - EUR | 155.533 | 138.859 | 125.145 | 75.101 | 62.401 | 78.969 | 87.644 | 232.048 | 144.531 | 274.221 |
Gross Profit/Loss - EUR | -10.307 | 12.160 | 1.431 | 4.280 | 23.552 | 46.460 | 60.641 | 210.899 | 212.555 | 58.639 |
Net Profit/Loss - EUR | -10.307 | 11.662 | 555 | 2.972 | 22.693 | 45.207 | 59.227 | 207.006 | 209.973 | 55.949 |
Employees | 7 | 7 | 6 | 4 | 3 | 3 | 2 | 3 | 5 | 5 |
Check the financial reports for the company - Elite Bio Champ Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 43.748 | 34.804 | 18.911 | 5.048 | 2.510 | 107.705 | 123.260 | 214.626 | 318.470 | 279.490 |
Current Assets | 40.573 | 36.896 | 30.999 | 16.274 | 36.182 | 77.973 | 59.221 | 317.825 | 263.982 | 358.793 |
Inventories | 1.143 | 74 | 87 | 155 | 10.112 | 10.451 | 9.821 | 71 | 63 | 338 |
Receivables | 32.503 | 28.676 | 28.116 | 15.800 | 23.871 | 62.467 | 43.598 | 210.841 | 226.882 | 326.166 |
Cash | 6.927 | 8.146 | 2.796 | 320 | 2.198 | 5.056 | 5.802 | 106.912 | 37.037 | 32.290 |
Shareholders Funds | -17.118 | -5.598 | -4.987 | -1.930 | 20.799 | 65.603 | 123.092 | 327.368 | 367.596 | 429.484 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 93 | 91 | 91 | 91 |
Debts | 90.280 | 70.261 | 56.218 | 23.685 | 18.390 | 120.901 | 60.060 | 24.897 | 35.714 | 29.485 |
Income in Advance | 12.514 | 8.293 | 3.927 | 0 | 0 | 0 | 0 | 180.247 | 180.806 | 180.258 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4931 - 4931" | |||||||||
CAEN Financial Year |
4631
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Elite Bio Champ Srl